申请人:Pfizer Inc.
公开号:US06579982B1
公开(公告)日:2003-06-17
The present invention relates to pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula
wherein X, Y, Ar1, Z, R1, R2 and R3 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
本发明涉及一种嘧啶-2,4,6-三酮金属蛋白酶抑制剂,其化学式中X、Y、Ar1、Z、R1、R2和R3如规范中所定义,并涉及制备该药物组合物和治疗炎症、癌症和其他疾病的方法。